Novel six-gene prognostic signature based on colon adenocarcinoma immune-related genes

BACKGROUND: Colon adenocarcinoma (COAD) is one of the most common gastrointestinal tumors worldwide, and immunotherapy is one of the most promising treatments for it. Identifying immune genes involved in the development and maintenance of cancer is key to the use of tumor immunotherapy. This study a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Rui, Gao, Zhuowei, Ju, Yongle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552517/
https://www.ncbi.nlm.nih.gov/pubmed/36221049
http://dx.doi.org/10.1186/s12859-022-04909-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552517/
https://www.ncbi.nlm.nih.gov/pubmed/36221049
http://dx.doi.org/10.1186/s12859-022-04909-2

Ejemplares similares